No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US Stock MarketDetailed Quotes
ATRA Atara Biotherapeutics
- 0.692
- -0.023-3.25%
Close Apr 18 16:00 ET
- 0.730
- +0.038+5.54%
Post 19:46 ET
82.56MMarket Cap-265P/E (TTM)
0.740High0.690Low830.30KVolume0.719Open0.715Pre Close596.04KTurnover0.92%Turnover RatioLossP/E (Static)119.36MShares3.01552wk High-0.83P/B62.51MFloat Cap0.19952wk Low--Dividend TTM90.37MShs Float65.560Historical High--Div YieldTTM7.01%Amplitude0.199Historical Low0.717Avg Price1Lot Size
Full Hours
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Trade Overview
Unit: --
Capital Trend
IntradayDayWeekMonth
No Data
News
Atara Biotherapeutics, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Atara Biotherapeutics, Inc. (NASDAQ:ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and
Atara Biotherapeutics Analyst Ratings
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 04/01/2024 220.29% Stifel $4.8 → $2.3 Maintains Hold 11/10/2023 -30.37% Goldman Sachs $3 → $0.5 Maintains
Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating
Stifel Adjusts Atara Biotherapeutics Price Target to $2.30 From $4.80, Maintains Hold Rating.
Analysts Offer Insights on Healthcare Companies: Atara Biotherapeutics (ATRA) and Embecta Corporation (EMBC)
Analysts Offer Insights on Healthcare Companies: Affimed (AFMD) and Atara Biotherapeutics (ATRA)
Atara Biotherapeutics' Profitability Hinges on Partners' Success With Ebvallo Amid Market Challenges
Comments
Im just adding a heads up to my previous post about upcoming BLA submission!
$Atara Biotherapeutics(ATRA.US$ PAY VERY CLOSE ATTENTION TO THE LAST 3 BULLET POINTS! This could be a catalyst for a large price increase? Even if its only a temporary increase? I want you to have ample opportunity to catch ahead of time if YOU CHOOSE? Not me choosing for YOU! NFA! Just a heads up for the possibility! Tab-cel U.S. BLA on Track for Submission in Q2 2024 Following Positive Pre-BLA Me...
10
14
Pay attention to the dates! Make a note !
$Atara Biotherapeutics(ATRA.US$ Tab-cel U.S. BLA on Track for Submission in Q2 2024 Following Positive Pre-BLA Meeting
Allogeneic CAR T Pipeline Expands Into Autoimmune Disease With Plans To Initiate a ATA3219 Lupus Nephritis Study in H2 2024, and Initial Clinical Data Expected H1 2025
ATA3219 NHL Study Enrolling With Initial Clinical Data Expected in Q4 2024
Cash Runway Into 2027 Enables Key Pipeline Readouts
Allogeneic CAR T Pipeline Expands Into Autoimmune Disease With Plans To Initiate a ATA3219 Lupus Nephritis Study in H2 2024, and Initial Clinical Data Expected H1 2025
ATA3219 NHL Study Enrolling With Initial Clinical Data Expected in Q4 2024
Cash Runway Into 2027 Enables Key Pipeline Readouts
4
1
New 13G! Did he get tired of naked SS? Hehehe
$Atara Biotherapeutics(ATRA.US$ Atara Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Citadel Advisors LLC(6.4%),Citadel Advisors Holdings LP(6.4%), etc.
SEC announcement· 4 mins ago
SEC announcement· 4 mins ago
News
$Atara Biotherapeutics(ATRA.US$ Atara Biotherapeutics Receives FDA Clearance Of IND Application In Lupus Nephritis For ATA3219
Moomoo 24/7· 1 min ago
Moomoo 24/7· 1 min ago
2
13G
$Atara Biotherapeutics(ATRA.US$ Atara Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Redmile Group, LLC(9.9%),Jeremy C. Green(9.9%)
SEC announcement· 16:29
SEC announcement· 16:29
1
Read more
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg
Benjamin’s : This for tomorrow or just reminder,? I didn’t see date.? TIA
TrytosaveabitOP Benjamin’s: It could move tomorrow? But it’s for a later date! They said April to sometime Q2! But that’s why I put it out now! GL
Jaguar8 : Very important drug. EBV virus unknowingly to most humans, it is 90% of population affected worldwide
TrytosaveabitOP Jaguar8: Dead on accurate as I’ve come to expect from you!
Jaguar8 TrytosaveabitOP:
You know we both love these clinical studies
View more comments...